Search for a doctor

Sameer R. Keole, M.D.

  1. Radiation Oncologist
Request an Appointment

Publications

  1. Laughlin BS, Corbin KS, Toesca DAS, Thorpe CS, Golafshar MA, Pockaj B, Cronin P, McGee LA, Halyard MY, Mutter RW, Keole SR, Park SS, Shumway DA, Vern-Gross TZ, Vallow L, Wong WW, DeWees TA, Vargas CE. Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery. Int J Radiat Oncol Biol Phys. 2024 Mar 15; 118 (4):1049-1059 Epub 2023 Oct 31
    View PubMed
  2. Zhang L, Holmes JM, Liu Z, Vora SA, Sio TT, Vargas CE, Yu NY, Keole SR, Schild SE, Bues M, Li S, Liu T, Shen J, Wong WW, Liu W. Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy. Med Phys. 2024 Feb; 51 (2):1484-1498 Epub 2023 Sept 25
    View PubMed
  3. Kang Y, Bues M, Halyard MY, McGee LA, Vern-Gross TZ, Wong WW, Keole SR, Vargas C, James SE, Ahmed SK, Archuleta JP, Ridgway AK, Lara PR, Fatyga M. Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization. Radiat Oncol. 2023 Sep 22; 18 (1):157 Epub 2023 Sept 22
    View PubMed
  4. Ahmed SK, Keole SR. Proton Therapy in the Adolescent and Young Adult Population. Cancers (Basel). 2023 Aug 25; 15 (17)
    View PubMed
  5. Duan J, Vargas CE, Yu NY, Laughlin BS, Toesca DS, Keole S, Rwigema JCM, Wong WW, Schild SE, Feng X, Chen Q, Rong Y. Incremental retraining, clinical implementation, and acceptance rate of deep learning auto-segmentation for male pelvis in a multiuser environment. Med Phys. 2023 Jul; 50(7):4079-4091. Epub 2023 Jun 07.
    View PubMed
  6. Shen J, Robertson DG, Bues M, Shipulin K, Liu W, Stoker J, Ashman JB, Lara P, Keole SR, Wong W, Vora SA. Technical note: Comprehensive evaluations of gantry and couch rotation isocentricities for implementing proton stereotactic radiosurgery. Med Phys. 2023 Jun; 50 (6):3359-3367 Epub 2023 Apr 06
    View PubMed
  7. Laughlin BS, Thorpe CS, DeWees TA, Voss MM, Chang JH, Hartsell WF, Sinesi CC, Rwigema JM, Keole SR, Gondi V, Vargas CE. Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003. Adv Radiat Oncol. 2023 May-Jun; 8 (3):101142 Epub 2022 Dec 09
    View PubMed
  8. Choo R, Hillman DW, Mitchell C, Daniels T, Vargas C, Rwigema JC, Corbin K, Keole S, Vora S, Merrell K, Stish B, Pisansky T, Davis BJ, Amundson A, Wong W. Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2023 Apr 1; 115 (5):1085-1094 Epub 2022 Nov 22
    View PubMed
  9. Hoppe BS, Petersen IA, Wilke BK, DeWees TA, Imai R, Hug EB, Fiore MR, Debus J, Fossati P, Yamada S, Orlandi E, Zhang Q, Bao C, Seidensaal K, May BC, Harrell AC, Houdek MT, Vallow LA, Rose PS, Haddock MG, Ashman JB, Goulding KA, Attia S, Krishnan S, Mahajan A, Foote RL, Laack NN, Keole SR, Beltran CJ, Welch EM, Karim M, Ahmed SK. Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design. Cancers (Basel). 2023 Mar 8; 15 (6) Epub 2023 Mar 08
    View PubMed
  10. Laughlin BS, Voss MM, Toesca DAS, Daniels T, Golafshar MA, Keole SR, Wong WW, Rwigema JC, Davis B, Schild SE, Stish BJ, Choo R, Lester S, DeWees TA, Vargas CE. Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy. Adv Radiat Oncol. 2023 Mar-Apr; 8 (2):101143 Epub 2022 Dec 10
    View PubMed
  11. Hoffman LM, Jaimes C, Mankad K, Mirsky DM, Tamrazi B, Tinkle CL, Kline C, Ramasubramanian A, Malbari F, Mangum R, Lindsay H, Horne V, Daniels DJ, Keole S, Grosshans DR, Young Poussaint T, Packer R, Cavalheiro S, Bison B, Hankinson TC, Muller HL, Bartels U, Warren KE, Chintagumpala M. Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. Neuro Oncol. 2023 Feb 14; 25 (2):224-233
    View PubMed
  12. Laughlin BS, Narang GL, Cheney SM, Humphreys MR, Vargas CE, Keole SR, Rwigema JM, Schild SE, Wong WW. Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience. Cancer Rep (Hoboken). 2023 Jan; 6 (1):e1672 Epub 2022 July 05
    View PubMed
  13. Hobbis D, Yu NY, Mund KW, Duan J, Rwigema JM, Wong WW, Schild SE, Keole SR, Feng X, Chen Q, Vargas CE, Rong Y. First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy Patients. Pract Radiat Oncol. 2023 Jul-Aug; 13(4):351-362. Epub 2023 Apr 06.
    View PubMed
  14. Laughlin BS, Yu NY, Lo S, Duan J, Welchel Z, Tinnon K, Beckett M, Schild SE, Wong WW, Keole SR, Rwigema JM, Vargas CE, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance. Cancers (Basel). 2022 Dec 21; 15 (1)
    View PubMed
  15. Laughlin BS, Lo S, Vargas CE, DeWees TA, Van der Walt C, Tinnon K, Beckett M, Hobbis D, Schild SE, Wong WW, Keole SR, Rwigema JM, Yu NY, Clouser E, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 1: Consistent Organs at Risk Management with Advanced Image Guidance. Cancers (Basel). 2022 Dec 20; 15 (1)
    View PubMed
  16. Yang Y, Rwigema JM, Vargas C, Yu NY, Keole SR, Wong WW, Schild SE, Bues M, Liu W, Shen J. Technical note: Investigation of dose and LET(d) effect to rectum and bladder by using non-straight laterals in prostate cancer receiving proton therapy. Med Phys. 2022 Dec; 49 (12):7428-7437 Epub 2022 Oct 18
    View PubMed
  17. Buras MR, Breen WG, Laack NN, Gross TV, Zaniletti I, Leavitt T, Golafshar MA, Voss MM, Mahajan A, Keole SR, Ahmed SK, Ulbrich A, Daniels TB, DeWees TA. Patient Versus Caregiver: Correlation and Differences in Pediatric Quality of Life Using a Prospective Registry in a Large-Volume, Multisite Practice. Int J Radiat Oncol Biol Phys. 2022 Nov 1; 114 (3):472-477 Epub 2022 July 15
    View PubMed
  18. Wong WW, Hillman DW, Daniels TB, Vargas CE, Rwigema JC, Corbin KS, Keole SR, Merrell KW, Stish BJ, Pisansky TM, Davis BJ, Mitchell CM, Choo R. A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of life. Prostate. 2022 Oct; 82 (14):1338-1345 Epub 2022 July 05
    View PubMed
  19. Laughlin BS, Anderson JD, Gagneur JD, Chungbin SJ, Bues M, Hobbis D, Fatyga M, Korte SM, Carroll SE, Vora S, Sio TT, Wong WW, Keole SR, Rong Y. Implementation of Photon Treatment Back-up Workflow at a High-Volume Proton Center: Safety, Quality, and Patient Considerations. Pract Radiat Oncol. 2022 Sep-Oct; 12 (5):e453-e459 Epub 2022 Mar 07
    View PubMed
  20. Liu AJ, Kosiorek HE, Ueberroth BE, Jaeger E, Ledet E, Kendi AT, Tzou K, Quevedo F, Choo R, Moore CN, Ho TH, Singh P, Keole SR, Wong WW, Sartor O, Bryce AH. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. Prostate. 2022 Sep; 82(12):1202-1209. Epub 2022 Jun 02.
    View PubMed
  21. Bhangoo RS, Petersen MM, Bulman GF, Vargas CE, Thorpe CS, Shen J, Wong WW, Rwigema JM, Daniels TB, Keole SR, Schild SE, Rong Y, DeWees TA. Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer. Int J Part Ther. 2022 Spring; 8 (4):37-46 Epub 2021 Sept 08
    View PubMed
  22. Thorpe CS, DeWees TA, Golafshar MA, Bhangoo RS, Vern-Gross TZ, McGee LA, Wong WW, Halyard MY, Keole SR, Vargas CE. Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry. J Patient Rep Outcomes. 2022 Jan 10; 6 (1):3
    View PubMed
  23. Laughlin BS, Silva AC, Vora SA, Keole SR, Wong WW, Schild MH, Schild SE. Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost. Front Oncol. 2022; 12:921465 Epub 2022 Aug 10
    View PubMed
  24. Laughlin BS, Bhangoo RS, Thorpe CS, Golafshar MA, DeWees TA, Anderson JD, Vern-Gross TZ, McGee LA, Wong WW, Halyard MY, Keole SR, Vargas CE. Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience. Front Oncol. 2022; 12:920739 Epub 2022 Aug 26
    View PubMed
  25. Bhangoo RS, DeWees TA, Thorpe CS, Petersen M, Hartsell WF, Chang J, Sinesi CC, Mishra MV, Mohammed N, McGee LA, Keole SR, Sweeney PJ, Gondi V, Vargas CE. Updated Toxicity and Quality-of-Life Outcomes From a Randomized Phase III Trial of Extreme Hypofractionated vs. Standard Fractionated Proton Therapy for Low-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 Nov 1; 111 (3S):e266
    View PubMed
  26. Thorpe CS, DeWees TA, Bhangoo RS, Petersen M, Chang JHC, Hartsell WF, Sinesi CC, Rwigema JC, Keole SR, Gondi V, Vargas CE. Randomized Phase III Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate: Analysis of Quality of Life and Toxicity, PCG GU 003. Int J Radiat Oncol Biol Phys. 2021 Nov 1; 111 (3S):e295
    View PubMed
  27. Choo R, Hillman DW, Daniels T, Vargas C, Rwigema JC, Corbin K, Keole S, Vora S, Merrell K, Stish B, Pisansky T, Davis B, Amundson A, Wong W. Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity. Int J Part Ther. 2021 Fall; 8 (2):41-50 Epub 2021 Sept 14
    View PubMed
  28. Yang Y, Vargas CE, Bhangoo RS, Wong WW, Schild SE, Daniels TB, Keole SR, Rwigema JM, Glass JL, Shen J, DeWees TA, Liu T, Bues M, Fatyga M, Liu W. Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT). Int J Radiat Oncol Biol Phys. 2021 Jul 15; 110 (4):1189-1199 Epub 2021 Feb 20
    View PubMed
  29. Bulman GF, Bhangoo RS, DeWees TA, Petersen MM, Thorpe CS, Wong WW, Rwigema JCM, Daniels TB, Keole SR, Schild SE, Vargas CE. Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy. Radiat Oncol J. 2021 Jun; 39 (2):122-128 Epub 2021 June 24
    View PubMed
  30. Anderson JD, Hammond JB, Kosiorek HE, Thorpe CS, Bhangoo RS, Pockaj BA, Gray RJ, Cronin PA, Rebecca AM, Casey WJ, Wong WW, Keole SR, Vern-Gross TZ, McGee LA, Halyard MY, DeWees TA, Vargas CE. Unplanned implant removal in locally advanced breast cancer. Breast J. 2021 May; 27 (5):466-471 Epub 2021 Mar 14
    View PubMed
  31. Patra DP, Hess RA, Turcotte EL, Welz ME, Rahme RJ, Maiti TK, Abi-Aad KR, AlMekkawi AK, Keole S, Lal D, Marino M, Mrugala M, Porter A, Vora S, Bendok BR. Surgical Outcomes with Midline versus Lateral Approaches for Cranial Base Chordomas: A Systematic Review and Meta-Analysis. World Neurosurg. 2020 Aug; 140:378-388.e2 Epub 2020 Apr 14
    View PubMed
  32. Waddle MR, Stross WC, Vallow LA, Naessens JM, White L, Meier S, Spaulding AC, Buskirk SJ, Trifiletti DM, Keole SR, Ma DJ, Bajaj GK, Laack NN, Miller RC. Impact of patient stage and disease characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM) International Journal of Radiation Oncology Biology Physics. 2020 Apr 1; 106(5):905-11. Epub 1900 Jan 01.
  33. Waddle MR, Stross WC, Vallow LA, Naessens JM, White L, Meier S, Spaulding AC, Buskirk SJ, Trifiletti DM, Keole SR, Ma DJ, Bajaj GK, Laack NN, Miller RC. Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM). Int J Radiat Oncol Biol Phys. 2020 Apr 1; 106 (5):905-911 Epub 2020 Jan 28
    View PubMed
  34. Shih HA, Rengan R, Apisarnthanarax S, Cheng CW, Daartz J, DeLaney TF, Hartsell WF, Indelicato DJ, Keole SR, Rosenthal S, Hartford AC. ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy. Am J Clin Oncol. 2020 Mar; 43 (3):149-159
    View PubMed
  35. Hayman JA, Dekker A, Feng M, Keole SR, McNutt TR, Machtay M, Martin NE, Mayo CS, Pawlicki T, Smith BD, Kudner R, Dawes S, Yu JB. Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus Paper. Pract Radiat Oncol. 2019 Nov; 9 (6):395-401 Epub 2019 Aug 21
    View PubMed
  36. Waddle MR, Kaleem TA, Stross WC, Malouff TD, White L, Li Z, Naessens J, Spaulding A, Aljabri D, Ma DJ, Keole S, Miller RC. Identifying the Most Costly Patients in Radiation Oncology and Predicting the Top Spenders. J Oncol Pract. 2019 Jun 17; JOP1800627 Epub 2019 June 17
    View PubMed
  37. Kang Y, Shen J, Liu W, Taylor PA, Mehrens HS, Ding X, Hu Y, Tryggestad E, Keole SR, Schild SE, Wong WW, Fatyga M, Bues M. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons. Radiat Oncol. 2019 Jun 17; 14 (1):108 Epub 2019 June 17
    View PubMed
  38. Stoker J, Vora S, Patel A, Grosshans D, Brown PD, Vern-Gross T, Bues M, Daniels T, Allred B, Uejo A, Kosiorek H, Bruso M, Keole S. Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy. Phys Imaging Radiat Oncol. 2018 Oct; 8:28-32 Epub 2018 Nov 27
    View PubMed
  39. Younkin JE, Bues M, Sio TT, Liu W, Ding X, Keole SR, Stoker JB, Shen J. Multiple energy extraction reduces beam delivery time for a synchrotron-based proton spot-scanning system. Adv Radiat Oncol. 2018 Jul-Sep; 3 (3):412-420 Epub 2018 Feb 23
    View PubMed
  40. Vargas CE, Schmidt MQ, Niska JR, Hartsell WF, Keole SR, Doh L, Chang JH, Sinesi C, Rodriquez R, Pankuch M, Larson GL. Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer. Adv Radiat Oncol. 2018 Jul-Sep; 3 (3):322-330 Epub 2018 Feb 23
    View PubMed
  41. Deng W, Liu W, Robertson DG, Bues M, Sio TT, Keole SR, Shen J. Technical Note: Using dual step wedge and 2D scintillator to achieve highly precise and robust proton range quality assurance. Med Phys. 2018 Jul; 45 (7):2947-2951 Epub 2018 May 20
    View PubMed
  42. Liu C, Schild SE, Chang JY, Liao Z, Korte S, Shen J, Ding X, Hu Y, Kang Y, Keole SR, Sio TT, Wong WW, Sahoo N, Bues M, Liu W. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 Jun 1; 101 (2):479-489 Epub 2018 Feb 14
    View PubMed
  43. Vargas CE, Hartsell WF, Dunn M, Keole SR, Doh L, Eisenbeisz E, Larson GL. Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002. Am J Clin Oncol. 2018 Feb; 41 (2):115-120
    View PubMed
  44. Vargas CE, Hartsell WF, Dunn M, Keole SR, Doh L, Eisenbeisz E, Larson GL. Hypofractionated versus standard fractionated proton-beam therapy for low-risk prostate cancer interim results of a randomized trial pcg gu 002 American Journal Of Clinical Oncology-cancer Clinical Trials. 2018 Feb; 41 (2):115-20
  45. Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW, Gray RJ, Wasif N, Vargas CE, Wong WW. Choosing wisely after publication of level I evidence in breast cancer radiotherapy. Breast Cancer (Dove Med Press). 2018; 10:31-37 Epub 2018 Feb 09
    View PubMed
  46. Waddle MR, Sio TT, Van Houten HK, Foote RL, Keole SR, Schild SE, Laack N, Daniels TB, Crown W, Shah ND, Miller RC. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients. Int J Radiat Oncol Biol Phys. 2017 Dec 1; 99 (5):1078-1082 Epub 2017 Aug 02
    View PubMed
  47. Wong WW, Anderson EM, Mohammadi H, Daniels TB, Schild SE, Keole SR, Choo CR, Tzou KS, Bryce AH, Ho TH, Quevedo FJ, Vora SA. Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017 Dec; 15(6):e969-e975. Epub 2017 Apr 26.
    View PubMed
  48. Shen J, Tryggestad E, Younkin JE, Keole SR, Furutani KM, Kang Y, Herman MG, Bues M. Technical Note: Using experimentally determined proton spot scanning timing parameters to accurately model beam delivery time. Med Phys. 2017 Oct; 44 (10):5081-5088 Epub 2017 Aug 30
    View PubMed
  49. Shen J, Allred BC, Robertson DG, Liu W, Sio TT, Remmes NB, Keole SR, Bues M. A novel and fast method for proton range verification using a step wedge and 2D scintillator. Med Phys. 2017 Sep; 44 (9):4409-4414 Epub 2017 July 31
    View PubMed
  50. Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II. Adv Radiat Oncol. 2017 Jul-Sep; 2 (3):437-454 Epub 2017 Mar 20
    View PubMed
  51. Schild MH, Schild SE, Wong WW, Vora SA, Keole SR, Vargas CE, Daniels TB, Ezzell GA, Nguyen BD, Roarke MC. A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT. Int J Radiat Oncol Biol Phys. 2017 Apr 1; 97 (5):1021-1025 Epub 2017 Feb 01
    View PubMed
  52. Rodgersa B, Jaroszewski DE, Ashman JB, Ruleb W, Sio TT, Keole SR. Advantages of Post-Mastectomy Proton Beam Therapy in a Breast Cancer Patient With Pectus Excavatum. Journal of Medical Cases.2017 Mar;8:(3):98-101.
  53. Davis BJ, Taira AV, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Showalter TN, Vapiwala N. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer. Brachytherapy. 2017 Mar - Apr; 16 (2):266-276 Epub 2016 Dec 07
    View PubMed
  54. McLaughlin PW, Liss AL, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, Movsas B, Prestidge BR, Showalter TN, Taira AV, Vapiwala N, Davis BJ, Expert Panel on Radiation OncologyProstate. ACR Appropriateness Criteria(R) Locally Advanced, High-Risk Prostate Cancer. Am J Clin Oncol. 2017 Feb; 40 (1):1-10
    View PubMed
  55. Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ, Expert Panel on Radiation Oncology-Prostate:. ACR Appropriateness Criteria((R)) external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Adv Radiat Oncol. 2017 Jan-Mar; 2 (1):62-84 Epub 2016 Oct 20
    View PubMed
  56. Chang JM, Kosiorek HE, Dueck AC, Casey WJ, Rebecca AM, Mahabir R, Patel SH, Keole SR, Wong WW, Vargas CE, Halyard MY, Gray RJ, Wasif N, Stucky CH, Pockaj BA. Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center. Am J Surg. 2016 Dec; 212 (6):1201-1210 Epub 2016 Sept 29
    View PubMed
  57. Wilkinson B, Morgan H, Gondi V, Larson GL, Hartsell WF, Laramore GE, Halasz LM, Vargas C, Keole SR, Grosshans DR, Shih HA, Mehta MP. Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96 (2S):E135
    View PubMed
  58. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6 (4):e117-e126 Epub 2016 Jan 26
    View PubMed
  59. Vargas CE, Hartsell WF, Dunn M, Keole SR, Doh L, Chang J, Larson GL. Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002. Rep Pract Oncol Radiother. 2016 May-Jun; 21 (3):207-12 Epub 2016 Mar 04
    View PubMed
  60. Liu W, Schild SE, Chang JY, Liao Z, Chang YH, Wen Z, Shen J, Stoker JB, Ding X, Hu Y, Sahoo N, Herman MG, Vargas C, Keole S, Wong W, Bues M. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1; 95 (1):523-533 Epub 2015 Nov 10
    View PubMed
  61. Anand A, Bues M, Rule WG, Keole SR, Beltran CJ, Yin J, Haddock MG, Hallemeier CL, Miller RC, Ashman JB. Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer. Radiother Oncol. 2015 Dec; 117 (3):505-8 Epub 2015 Nov 17
    View PubMed
  62. Liu W, Liao Z, Schild SE, Liu Z, Li H, Li Y, Park PC, Li X, Stoker J, Shen J, Keole S, Anand A, Fatyga M, Dong L, Sahoo N, Vora S, Wong W, Zhu XR, Bues M, Mohan R. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers. Pract Radiat Oncol. 2015 Mar-Apr; 5 (2):e77-86 Epub 2014 Sept 11
    View PubMed
  63. Schild MH, Schild SE, Wong WW, Vora SA, Silva AC, Silva AM, Daniels TB, Keole SR. Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost. OMICS J Radiol. 2014 Dec; 3 (4)
    View PubMed
  64. Keole S, Ashman JB, Daniels TB. Proton therapy for sarcomas. Cancer J. 2014 Nov-Dec; 20(6):409-14.
    View PubMed
  65. Schild SE, Rule WG, Ashman JB, Vora SA, Keole S, Anand A, Liu W, Bues M. Proton beam therapy for locally advanced lung cancer: A review. World J Clin Oncol. 2014 Oct 10; 5 (4):568-75
    View PubMed
  66. Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014; 16 (2):67-75
    View PubMed
  67. Indelicato DJ, Keole SR, Lagmay JP, Morris CG, Gibbs CP Jr, Scarborough MT, Islam S, Marcus RB Jr. Chest wall Ewing sarcoma family of tumors: long-term outcomes. Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):158-66. Epub 2010 Aug 21.
    View PubMed
  68. Zheng Y, Ramirez E, Mascia A, Ding X, Okoth B, Zeidan O, Hsi W, Harris B, Schreuder AN, Keole S. Commissioning of output factors for uniform scanning proton beams. Med Phys. 2011 Apr; 38(4):2299-306.
    View PubMed
  69. Whaley JT, Indelicato DJ, Morris CG, Hinerman RW, Amdur RJ, Mendenhall WM, Keole SR, Marcus RB Jr. Ewing tumors of the head and neck. Am J Clin Oncol. 2010 Aug; 33(4):321-6.
    View PubMed
  70. Indelicato DJ, Keole SR, Shahlaee AH, Morris CG, Gibbs CP Jr, Scarborough MT, Pincus DW, Marcus RB Jr. Spinal and paraspinal Ewing tumors. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1463-71. Epub 2009 Jul 23.
    View PubMed
  71. Vargas C, Saito AI, Hsi WC, Indelicato D, Falchook A, Zengm Q, Oliver K, Keole S, Dempsey J. Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon. Am J Clin Oncol. 2010 Feb; 33(1):11-6.
    View PubMed
  72. Mendenhall WM, Henderson RH, Nichols RC, Keole SR, Mendenhall NP. Postprostatectomy radiotherapy for prostate cancer. Am J Clin Oncol. 2009 Oct; 32(5):529-34.
    View PubMed
  73. Mendenhall WM, Henderson RH, Indelicato DJ, Keole SR, Mendenhall NP. Erectile dysfunction after radiotherapy for prostate cancer. Am J Clin Oncol. 2009 Aug; 32(4):443-7.
    View PubMed
  74. Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Oncol. 2009 Apr; 32(2):180-6.
    View PubMed
  75. Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72(5):1426-33. Epub 2008 Aug 30.
    View PubMed
  76. Shi W, Indelicato DJ, Keole SR, Morris CG, Scarborough MT, Gibbs PC, Zlotecki RA. Radiation treatment for Ewing family of tumors in adults: the University of Florida experience. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1140-5. Epub 2008 May 29.
    View PubMed
  77. Indelicato DJ, Keole SR, Shahlaee AH, Shi W, Morris CG, Marcus RB Jr. Definitive radiotherapy for ewing tumors of extremities and pelvis: long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys. 2008 Nov 1; 72(3):871-7. Epub 2008 May 01.
    View PubMed
  78. Indelicato DJ, Keole SR, Shahlaee AH, Shi W, Morris CG, Gibbs CP Jr, Scarborough MT, Marcus RB Jr. Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: the University of Florida experience. Int J Radiat Oncol Biol Phys. 2008 Sep 1; 72(1):41-8. Epub 2008 Jan 30.
    View PubMed
  79. Vargas C, Wagner M, Indelicato D, Fryer A, Horne D, Chellini A, McKenzie C, Lawlor P, Mahajan C, Li Z, Lin L, Keole S. Image guidance based on prostate position for prostate cancer proton therapy. Int J Radiat Oncol Biol Phys. 2008 Aug 1; 71(5):1322-8. Epub 2008 May 28.
    View PubMed
  80. Vargas C, Wagner M, Mahajan C, Indelicato D, Fryer A, Falchook A, Horne D, Chellini A, McKenzie C, Lawlor P, Li Z, Lin L, Keole S. Proton therapy coverage for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2008 Apr 1; 70(5):1492-501.
    View PubMed
  81. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):744-51. Epub 2007 Sep 27.
    View PubMed
  82. Indelicato DJ, Keole SR, Shahlaee AH, Shi W, Morris CG, Gibbs CP Jr, Scarborough MT, Marcus RB Jr. Long-term clinical and functional outcomes after treatment for localized Ewing's tumor of the lower extremity. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):501-9. Epub 2007 Sep 12
    View PubMed
  83. Vargas C, Mahajan C, Fryer A, Indelicato D, Henderson RH, McKenzie C, Horne D, Chellini A, Lawlor P, Li Z, Oliver K, Keole S. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1110-6.
    View PubMed
  84. Saad A, Lo S, Han I, Keole S, Lee CP, Tekyi-Mensah S, Munkarah A, Malone J, Morris R, Deppe G. Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis. Am J Clinical Oncology. 2006 Jun 1; 65(2):481-5.
  85. Schoenfeld GO, Amdur RJ, Schmalfuss IM, Morris CG, Keole SR, Mendenhall WM, Marcus RB Jr. Low-dose prophylactic craniospinal radiotherapy for intracranial germinoma. Int J Radiat Oncol Biol Phys. 2006 Jun 1; 65(2):481-5. Epub 2006 Mar 10.
    View PubMed
  86. Saad A, Lo SS, Han I, Keole S, Lee CP, Tekyi-Mensah S, Munkarah A, Malone J, Morris R, Deppe G. Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis. Am J Clin Oncol. 2004 Jun; 27(3):256-63.
    View PubMed
  87. Forman JD, Keole S, Bolton S, Tekyi-Mensah S. Association of prostate size with urinary morbidity following mixed conformal neutron and photon irradiation. Int J Radiat Oncol Biol Phys. 1999 Nov 1; 45(4):871-5.
    View PubMed
PST-20227208